Essential thrombocythemia (ET) is characterized by increased platelets and prevalent thrombosis. An acquired Von Willebrand factor (VWF) disease has been hypothesized and inconsistently associated with extreme thrombocytosis or rare bleedings in ET. Whether VWF is modified in ET patients with controlled platelet count remains unclear.
Lancellotti, S., Dragani, A., Ranalli, P., Petrucci, G., Basso, M., Tartaglione, R., Rocca, B., De Cristofaro, R., Qualitative and quantitative modifications of von willebrand factor in patients with essential thrombocythemia and controlled platelet count, <<JOURNAL OF THROMBOSIS AND HAEMOSTASIS>>, 2015; 13 (7): 1226-1237. [doi:10.1111/jth.12967] [http://hdl.handle.net/10807/66073]
Qualitative and quantitative modifications of von willebrand factor in patients with essential thrombocythemia and controlled platelet count
Lancellotti, Stefano;Petrucci, Giovanna;Basso, Maria;Tartaglione, Raffaele;Rocca, Bianca;De Cristofaro, Raimondo
2015
Abstract
Essential thrombocythemia (ET) is characterized by increased platelets and prevalent thrombosis. An acquired Von Willebrand factor (VWF) disease has been hypothesized and inconsistently associated with extreme thrombocytosis or rare bleedings in ET. Whether VWF is modified in ET patients with controlled platelet count remains unclear.
| File | Dimensione | Formato | |
|---|---|---|---|
|
66073OA.pdf
non disponibili
Tipologia file ?:
Versione Editoriale (PDF)
Licenza:
Non specificato
Dimensione
536.21 kB
Formato
Unknown
|
536.21 kB | Unknown | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
